Teva Pharmaceutical Industries Limited
TEVA | NYSE
$39.23
-$0.83 (-2.07%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 3.56B | 3.3B | 3.23B | 2.8B | 2.17B | 2.18B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 8M | n/a | n/a | n/a |
Other Long-Term Assets | 404.99M | 462M | 462M | 441M | 515M | 538M |
Receivables | 3.71B | 3.06B | 3.41B | 3.7B | 4.53B | 4.58B |
Inventory | 3.18B | 3.01B | 4.02B | 3.83B | 3.82B | 4.4B |
Other Current Assets | 2.38B | 2.18B | 575M | 559M | 986M | 899M |
Total Current Assets | 13.95B | 12.55B | 12.49B | 12.05B | 12.57B | 13.01B |
Property-Plant & Equipment | 4.42B | 4.95B | 6.15B | 6.16B | 6.48B | 6.85B |
Goodwill & Intangibles | 19.78B | 19.57B | 22.56B | 23.9B | 27.51B | 29.55B |
Total Long-Term Assets | 26.8B | 26.77B | 30.99B | 31.96B | 35.09B | 37.63B |
Total Assets | 40.75B | 39.33B | 43.48B | 44.01B | 47.67B | 50.64B |
Account Payables | 2.53B | 2.2B | 2.6B | 1.89B | 1.69B | 1.76B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 7.29B |
Short-Term Debt | 1.82B | 1.78B | 1.67B | 2.11B | 1.43B | 3.19B |
Other Current Liabilities | 8.37B | 6.02B | 5.2B | 5.32B | 5.71B | 246M |
Total Current Liabilities | 13.46B | 12.8B | 12.25B | 11.47B | 11.03B | 13.16B |
Long-Term Debt | 15.27B | 16B | 18.16B | 19.1B | 21.62B | 22.73B |
Other Long-Term Liabilities | 3.52B | 4.03B | 4.02B | 3.94B | 2.58B | 2.24B |
Total Long-Term Liabilities | 19.38B | 20.81B | 23.11B | 23.94B | 25.4B | 26.42B |
Total Liabilities | 32.83B | 33.61B | 35.35B | 35.41B | 36.42B | 39.58B |
Total Debt | 17.38B | 18.08B | 20.15B | 21.56B | 23.46B | 26.4B |
Book Value | 7.91B | 5.72B | 8.13B | 8.6B | 11.24B | 11.06B |
Book Value Per Share | 6.75 | 5.06 | 7.26 | 7.75 | 10.16 | 10.10 |
Common Stock | 58M | 58M | 57M | 57M | 57M | 57M |
Retained Earnings | -13.76B | -15.17B | -13.53B | -12.98B | -10.53B | -10.95B |
Comprehensive Income | -2.39B | -3.15B | -2.7B | -2.84B | -2.68B | -2.4B |
Shareholders Equity | 7.91B | 5.37B | 7.51B | 7.8B | 10.28B | 10.03B |
Total Investments | n/a | n/a | 8M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TEVA